medigraphic.com
Revista Médica Sinergia

2022, Number 11

<< Back Next >>

Revista Médica Sinergia 2022; 7 (11)

Update on Watch and Wait management in rectal cancer

Gutiérrez LC

Language: Spanish
References: 18
Page:
PDF size: 192.98 Kb.


ABSTRACT

The treatment of rectal cancer continues to be mainly surgical, however, this management entails a series of comorbidities and possible complications for the patient, such as: fecal or urinary incontinence, sexual dysfunction and a high possibility of a permanent ostomy and its complications. However, it has been seen that up to a quarter of pathological specimens show a complete pathological response after neoadjuvant therapy. This is why, with the idea of avoiding these complications after surgery, the idea of Watch and Wait management was born. Where, if after neoadjuvant treatment the patient obtains a complete response to treatment, he or she goes on to a program of close observation and, if maintained, would avoid radical surgery, which in various studies has shown oncological results similar to surgical management. Being a novel management, it requires clarifying various aspects, including: the patient who would benefit the most, the neoadjuvant therapy to be performed, the evaluation of the clinical response and the follow-up of the patient.


REFERENCES

  1. Pinto JC, Pereira AD, Pimenta A, Pedro C, Fernández G, Marques I, et al. Low rectal cancer treatment strategies: a cohort study assessing watch and wait. J Cancer Res Clin Oncol. Oct, 2020;146(10):2631–8.

  2. López-Campos F, Martín-Martín M, Fornell-Pérez R, García-Pérez JC, Die-Trill J, Fuentes-Mateos R, et al. Watch and wait approach in rectal cancer: Current controversies and future directions. World J Gastroenterol. Aug 07, 2020;26(29):4218–39.

  3. Glynne-Jones R, Hughes R. Complete Response after Chemoradiotherapy in Rectal Cancer (Watch-and-Wait): Have we Cracked the Code? Clin Oncol (R Coll Radiol). Feb, 2016;28(2):152–60.

  4. Tulin A, Nitipir C, Slavu I, Braga V, Mihaila D, Alecu L. Watch and Wait Strategy for Rectal Cancer: 15 Years After the First Published Study. Are We any Closer to the Non-operative Management of Rectal Cancer? Revista Chirurgia [Internet]. 2019 [cited Aug 27, 2022];114(2):174. Available from: http://www.revistachirurgia.ro/pdfs/2019-2-174.pdf

  5. Fokas E, Appelt A, Glynne-Jones R, Beets G, Pérez R, García-Aguilar J, et al. International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer. Nat Rev Clin Oncol [Internet]. Dec, 2021 [cited Sep 1, 2022];18(12):805–16. Available from: https://www.nature.com/articles/s41571-021-00538-5

  6. Bernier L, Balyasnikova S, Tait D, Brown G. Watch-and-Wait as a Therapeutic Strategy in Rectal Cancer. Curr Colorectal Cancer Rep [Internet]. Apr, 2018 [cited Aug 29, 2022];14(2):37–55. Available from: http://link.springer.com/10.1007/s11888-018-0398-5

  7. Haak HE, Maas M, Lambregts DMJ, Beets-Tan RGH, Beets GL, Melenhorst J, et al. Is watch and wait a safe and effective way to treat rectal cancer in older patients? European Journal of SurgicalOncology [Internet]. Mar, 2020 [cited Sep 1, 2022];46(3):358–62. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0748798320300056

  8. Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology [Internet]. Jul, 2017 [cited Jul 31, 2022];28:iv22–40. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0923753419421522

  9. Wei IH, García-Aguilar J. Non-operative management of rectal cancer: understanding tumor biology. Minerva Chir [Internet]. Nov, 2018 [cited Sep 1, 2022];73(6). Available from: https://www.minervamedica.it/index2.php?show=R06Y2018N06A0601

  10. Capdevila J, Gómez MA, Guillot M, Páez D, Pericay C, Safont MJ, et al. SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021). Clin Transl Oncol [Internet]. Apr, 2022 [cited Jul 31, 2022];24(4):646–57. Available from: https://link.springer.com/10.1007/s12094-022-02816-9

  11. Cercek A, Roxburgh CSD, Strombom P, Smith JJ, Temple LKF, Nash GM, et al. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer. JAMA Oncol [Internet]. Jun 14, 2018 [cited Aug 28, 2022];4(6):e180071. Available from: http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jamaoncol.2018.0071

  12. Das P, Skibber JM, Rodríguez-Bigas MA, Feig BW, Chang GJ, Wolff RA, et al. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer. May 1, 2007;109(9):1750–5.

  13. Yuval JB, Thompson HM, García-Aguilar J. Organ Preservation in Rectal Cancer. J Gastrointest Surg [Internet]. Aug, 2020 [cited Sep 2, 2022];24(8):1880–8. Available from: https://link.springer.com/10.1007/s11605-020-04583-w

  14. Habr-Gama A, São Julião G, Vailati B, Castro I, Raffaele D. Management of the Complete Clinical Response. Clinics in Colon and Rectal Surgery [Internet]. Nov, 2017 [cited 2022 Sep 2];30(05):387–94. Available from: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0037-1606116

  15. Al-Najami I, Jones HJ, Dickson EA, Muirhead R, Deding U, James DR, et al. Rectal cancer: Watch-and-wait and continuing the rectal-preserving strategy with local excision for incomplete response or limited regrowth. Surg Oncol. Jun, 2021;37:101574.

  16. Fernández LM, Figueiredo NL, Habr-Gama A, São Julião GP, Vieira P, Vailati BB, et al. Salvage Surgery With Organ Preservation for Patients With Local Regrowth After Watch and Wait: Is It Still Possible? Dis Colon Rectum. Aug, 2020;63(8):1053–62.

  17. Geubels BM, Meyer VM, van Westreenen HL, Beets GL, Grotenhuis BA, On Behalf Of The Dutch Watch And Wait Consortium null. Role of Local Excision for Suspected Regrowth in a Watch and Wait Strategy for Rectal Cancer. Cancers (Basel). Jun 23, 2022;14(13):3071.

  18. Pascual-Russo A, Milito D, Facio L, Furia M, Forestier V, Iseas S, et al. Mejor calidad de vida y menor incontinencia fecal en pacientes con cáncer de recto con la estrategia de seguimiento watch and wait. Revista de Gastroenterología de México [Internet]. Oct, 2021 [citado el 03 de setiembre, 2022];86(4):340–7. Disponible a partir de: https://linkinghub.elsevier.com/retrieve/pii/S0375090620300902




2020     |     www.medigraphic.com